Filing Details
- Accession Number:
- 0001104659-10-064308
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-27 16:09:19
- Reporting Period:
- 2010-12-22
- Filing Date:
- 2010-12-27
- Accepted Time:
- 2010-12-27 16:09:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874015 | Isis Pharmaceuticals Inc | ISIS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1073387 | Frank C Bennett | C/O Isis Pharmaceuticals, Inc. 1896 Rutherford Road Carlsbad CA 92008 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-12-22 | 6,200 | $9.63 | 6,761 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-12-22 | 6,200 | $10.52 | 561 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-12-23 | 1,500 | $9.63 | 2,061 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-12-23 | 1,500 | $10.53 | 561 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-12-22 | 6,200 | $0.00 | 6,200 | $9.63 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-12-23 | 1,500 | $0.00 | 1,500 | $9.63 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,800 | 2005-01-02 | 2011-01-01 | No | 4 | M | Direct |
12,300 | 2005-01-02 | 2011-01-01 | No | 4 | M | Direct |
Footnotes
- Acquired as a result of exercising a stock option that was scheduled to expire on 1/1/11. The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/16/10.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/16/10.